DanCann Pharma A/S (NGM:DANCAN)

DanCann Pharma Revenue

In the year 2024, DanCann Pharma had annual revenue of 7.37M DKK with 3.06% growth. DanCann Pharma had revenue of 959.00K in the quarter ending December 31, 2024, a decrease of -40.47%.

• Revenue: 7.37M DKK
• Revenue Growth: +3.06%
• P/S Ratio: 0.73
• Revenue / Employee: 614.33K DKK
• Employees: 12
• Market Cap: 8.31M SEK

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.37M	219.00K	3.06%
Dec 31, 2023	7.15M	-36.00K	-0.50%
Dec 31, 2022	7.19M	4.88M	211.89%
Dec 31, 2021	2.31M	-	-
Dec 31, 2020	-	-	-